Comparison of bivalirudin with heparin versus abciximab with heparin for primary percutaneous coronary intervention in “Real World” practice

Conclusion: In this “real-world” observational study, there was no significant difference in the clinical outcome of PPCI for patients who had abciximab or bivalirudin after initial pre-treatment with UFH.

Source: Cardiovascular Revascularization Medicine - August 26, 2013 Category: Cardiology Authors: Refai Showkathali, John R. Davies, Michael Parker, Wasing Taggu, Kare H. Tang, Gerald J. Clesham, Reto A. Gamma, Jeremy W. Sayer, Rajesh K. Aggarwal, Paul A. Kelly Tags: Clinical Source Type: research